filmov
tv
COVID-19 and leukaemia: what more do we know? ONLINE WEBINAR
Показать описание
INFORMATION CORRECT AS OF 28/09/2021.
This webinar explored the latest guidance and recommendations for leukaemia patients, including those who are immunocompromised and the clinically extremely vulnerable. Are there different recommendations for different groups of patients?
The webinar provided updates on the latest COVID-19 data across the leukaemia types: vaccinations, responses, and looked at what this means in relation to protection. Information about COVID-19 boosters and progress with anti-COVID-19 monoclonal antibody research trials for the immune compromised were also discussed.
We were joined by:
Dr Helen Parry, National Institute for Health Research (NIHR), Birmingham University and Queen Elizabeth Hospital Birmingham. Helen is a clinical lecturer leading research into optimising vaccination strategies and minimising infection risk in patients with leukaemia.
This webinar explored the latest guidance and recommendations for leukaemia patients, including those who are immunocompromised and the clinically extremely vulnerable. Are there different recommendations for different groups of patients?
The webinar provided updates on the latest COVID-19 data across the leukaemia types: vaccinations, responses, and looked at what this means in relation to protection. Information about COVID-19 boosters and progress with anti-COVID-19 monoclonal antibody research trials for the immune compromised were also discussed.
We were joined by:
Dr Helen Parry, National Institute for Health Research (NIHR), Birmingham University and Queen Elizabeth Hospital Birmingham. Helen is a clinical lecturer leading research into optimising vaccination strategies and minimising infection risk in patients with leukaemia.
1:13:07
COVID-19 and leukaemia: what more do we know? ONLINE WEBINAR
0:45:03
COVID-19 and Acute Leukaemia Webinar
0:07:33
Managing acute myeloid leukaemia during the COVID-19 pandemic
0:01:38
How COVID-19 Has Impacted Clinical Trials for Chronic Lymphocytic Leukemia
1:32:07
Blood Cancer Care and COVID-19 Q&A
0:23:48
COVID-19 vaccination & lymphoma/CLL – what does this mean for Australian patients?
0:02:04
No link between COVID-19 vaccines and leukemia: health authorities
1:02:08
COVID-19 Vaccines Part II: The CDC Guidelines for Lymphoma and CLL Patients | LRF Webinars
0:03:41
COVID-19 vaccination in CLL
0:42:02
The COVID-19 pandemic emergency and management of acute leukemia: challenges and options
0:03:32
CLL and COVID-19: patient outcomes
0:12:20
Omicron Variant of COVID-19 Risk to Chronic Lymphocytic Leukemia (CLL) Patients
0:02:58
Treating leukemia during the COVID-19 pandemic
0:04:01
Treating acute lymphoblastic leukaemia in the era of COVID-19
0:10:33
How should we manage patients with acute lymphoblastic leukaemia during COVID-19?
1:04:51
COVID 19 and Cancer - What You Need to Know Now
1:01:14
Ask the Experts: Blood Cancer and COVID-19 Vaccines
0:50:50
COVID-19 in 2023: An update for people with blood cancers
0:57:21
Risks and Responses: COVID 19 Vaccines and Blood Cancer Patients
0:08:20
COVID-19 information for cancer patients
0:05:50
New COVID-19 Staff Safety Policies at LLS
0:01:57
COVID-19 vaccine and blood cancer
1:48:58
CHALLENGES IN TREATMENT OF PATIENTS WITH ACUTE LEUKEMIA AND COVID-19
1:02:52
LLS Research Now – Update: Emerging Research on COVID-19 and Blood Cancer
Комментарии